These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

519 related items for PubMed ID: 22309668

  • 1. Technologies for enhanced efficacy of DNA vaccines.
    Saade F, Petrovsky N.
    Expert Rev Vaccines; 2012 Feb; 11(2):189-209. PubMed ID: 22309668
    [Abstract] [Full Text] [Related]

  • 2. DNA vaccines: an historical perspective and view to the future.
    Liu MA.
    Immunol Rev; 2011 Jan; 239(1):62-84. PubMed ID: 21198665
    [Abstract] [Full Text] [Related]

  • 3. Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.
    Buchan S, Grønevik E, Mathiesen I, King CA, Stevenson FK, Rice J.
    J Immunol; 2005 May 15; 174(10):6292-8. PubMed ID: 15879128
    [Abstract] [Full Text] [Related]

  • 4. Tapping the Potential of DNA Delivery with Electroporation for Cancer Immunotherapy.
    Kraynyak KA, Bodles-Brakhop A, Bagarazzi M.
    Curr Top Microbiol Immunol; 2017 May 15; 405():55-78. PubMed ID: 25682101
    [Abstract] [Full Text] [Related]

  • 5. DNA vaccines to attack cancer: Strategies for improving immunogenicity and efficacy.
    Tiptiri-Kourpeti A, Spyridopoulou K, Pappa A, Chlichlia K.
    Pharmacol Ther; 2016 Sep 15; 165():32-49. PubMed ID: 27235391
    [Abstract] [Full Text] [Related]

  • 6. DNA vaccines, electroporation and their applications in cancer treatment.
    Lee SH, Danishmalik SN, Sin JI.
    Hum Vaccin Immunother; 2015 Sep 15; 11(8):1889-900. PubMed ID: 25984993
    [Abstract] [Full Text] [Related]

  • 7. Current progress of DNA vaccine studies in humans.
    Lu S, Wang S, Grimes-Serrano JM.
    Expert Rev Vaccines; 2008 Mar 15; 7(2):175-91. PubMed ID: 18324888
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of cellular immune response to a prostate cancer DNA vaccine by intradermal electroporation.
    Roos AK, Moreno S, Leder C, Pavlenko M, King A, Pisa P.
    Mol Ther; 2006 Feb 15; 13(2):320-7. PubMed ID: 16185933
    [Abstract] [Full Text] [Related]

  • 9. Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.
    Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K.
    Vaccine; 2009 Jun 08; 27(28):3692-6. PubMed ID: 19428161
    [Abstract] [Full Text] [Related]

  • 10. Cancer Vaccines, Adjuvants, and Delivery Systems.
    Paston SJ, Brentville VA, Symonds P, Durrant LG.
    Front Immunol; 2021 Jun 08; 12():627932. PubMed ID: 33859638
    [Abstract] [Full Text] [Related]

  • 11. DNA vaccination and gene therapy: optimization and delivery for cancer therapy.
    Bodles-Brakhop AM, Draghia-Akli R.
    Expert Rev Vaccines; 2008 Sep 08; 7(7):1085-101. PubMed ID: 18767956
    [Abstract] [Full Text] [Related]

  • 12. Coadministration of a Plasmid Encoding HIV-1 Gag Enhances the Efficacy of Cancer DNA Vaccines.
    Lambricht L, Vanvarenberg K, De Beuckelaer A, Van Hoecke L, Grooten J, Ucakar B, Lipnik P, Sanders NN, Lienenklaus S, Préat V, Vandermeulen G.
    Mol Ther; 2016 Sep 08; 24(9):1686-96. PubMed ID: 27434590
    [Abstract] [Full Text] [Related]

  • 13. Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.
    Bråve A, Gudmundsdotter L, Sandström E, Haller BK, Hallengärd D, Maltais AK, King AD, Stout RR, Blomberg P, Höglund U, Hejdeman B, Biberfeld G, Wahren B.
    Vaccine; 2010 Nov 29; 28(51):8203-9. PubMed ID: 20951666
    [Abstract] [Full Text] [Related]

  • 14. Electroporation delivery of DNA vaccines: prospects for success.
    Sardesai NY, Weiner DB.
    Curr Opin Immunol; 2011 Jun 29; 23(3):421-9. PubMed ID: 21530212
    [Abstract] [Full Text] [Related]

  • 15. Bacteria as DNA vaccine carriers for genetic immunization.
    Schoen C, Stritzker J, Goebel W, Pilgrim S.
    Int J Med Microbiol; 2004 Oct 29; 294(5):319-35. PubMed ID: 15532991
    [Abstract] [Full Text] [Related]

  • 16. The future of human DNA vaccines.
    Li L, Saade F, Petrovsky N.
    J Biotechnol; 2012 Dec 31; 162(2-3):171-82. PubMed ID: 22981627
    [Abstract] [Full Text] [Related]

  • 17. Effect of tape stripping and adjuvants on immune response after intradermal DNA electroporation.
    Vandermeulen G, Daugimont L, Richiardi H, Vanderhaeghen ML, Lecouturier N, Ucakar B, Préat V.
    Pharm Res; 2009 Jul 31; 26(7):1745-51. PubMed ID: 19384465
    [Abstract] [Full Text] [Related]

  • 18. Strategies for improved formulation and delivery of DNA vaccines to veterinary target species.
    van Drunen Littel-van den Hurk S, Babiuk SL, Babiuk LA.
    Immunol Rev; 2004 Jun 31; 199():113-25. PubMed ID: 15233730
    [Abstract] [Full Text] [Related]

  • 19. Genetic immunization with plasmid DNA mediated by electrotransfer.
    Rochard A, Scherman D, Bigey P.
    Hum Gene Ther; 2011 Jul 31; 22(7):789-98. PubMed ID: 21631165
    [Abstract] [Full Text] [Related]

  • 20. DNA vaccines.
    Reyes-Sandoval A, Ertl HC.
    Curr Mol Med; 2001 May 31; 1(2):217-43. PubMed ID: 11899073
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.